amphetamine has been researched along with Bruxism in 1 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Bruxism: A disorder characterized by grinding and clenching of the teeth.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Addictive substances with bruxism as potential adverse effect are alcohol, heroin, methamphetamine, methylenedioxymethamphetamine, nicotine and piperazines." | 2.61 | [Series: Medicaments and oral healthcare. Medicaments and addictive substances, potentially inducing or ameliorating bruxism]. ( de Baat, C; Lobbezoo, F; Verhoeff, MC; Vissink, A; Zweers, PGMA, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Baat, C | 1 |
| Verhoeff, MC | 1 |
| Zweers, PGMA | 1 |
| Vissink, A | 1 |
| Lobbezoo, F | 1 |
1 review available for amphetamine and Bruxism
| Article | Year |
|---|---|
[Series: Medicaments and oral healthcare. Medicaments and addictive substances, potentially inducing or ameliorating bruxism].
Topics: Amphetamine; Anticonvulsants; Bruxism; Humans; Netherlands; Selective Serotonin Reuptake Inhibitors; | 2019 |